Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
2.350
+0.050 (2.17%)
At close: Aug 5, 2026, 4:00 PM EDT
2.350
0.00 (0.00%)
After-hours: Aug 5, 2026, 4:18 PM EDT
Neuronetics Revenue
Neuronetics had revenue of $34.45M in the quarter ending March 31, 2026, with 7.75% growth. This brings the company's revenue in the last twelve months to $151.64M, up 69.52% year-over-year. In the year 2025, Neuronetics had annual revenue of $149.16M with 99.17% growth.
Revenue (ttm)
$151.64M
Revenue Growth
+69.52%
P/S Ratio
1.07
Revenue / Employee
$230,450
Employees
658
Market Cap
163.53M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 149.16M | 74.27M | 99.17% |
| Dec 31, 2024 | 74.89M | 3.54M | 4.96% |
| Dec 31, 2023 | 71.35M | 6.14M | 9.42% |
| Dec 31, 2022 | 65.21M | 9.89M | 17.89% |
| Dec 31, 2021 | 55.31M | 6.07M | 12.32% |
| Dec 31, 2020 | 49.24M | -13.41M | -21.41% |
| Dec 31, 2019 | 62.66M | 9.88M | 18.72% |
| Dec 31, 2018 | 52.78M | 12.34M | 30.53% |
| Dec 31, 2017 | 40.43M | 6.21M | 18.13% |
| Dec 31, 2016 | 34.23M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Inogen | 351.50M |
| Quanterix | 144.98M |
| InfuSystem Holdings | 142.40M |
| Owlet | 107.06M |
| AVITA Medical | 72.35M |
| CVRx, Inc. | 59.07M |
| Apyx Medical | 55.90M |
| Rapid Micro Biosystems | 34.38M |
STIM News
- 2 days ago - Neuronetics and Jorey Chernett Announce Shared Vision - GlobeNewsWire
- 5 days ago - Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 8 days ago - Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland - GlobeNewsWire
- 8 days ago - Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call - GlobeNewsWire
- 16 days ago - Neuronetics appoints Nir Naor as CFO, CLO Andrew Macan to step down - TheFly
- 16 days ago - Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes - GlobeNewsWire
- 16 days ago - Neuronetics initiated with a Buy at BTIG - TheFly
- 4 weeks ago - Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026 - GlobeNewsWire